Literature DB >> 18649737

Laparoscopic radical prostatectomy: initial experience of robotic surgery in Taiwan.

Sheng-Tang Wu1, Ke-Hung Tsui, Shou-Hung Tang, Dai-Lung Char, Dah-Shyong Yu, Chung-Yran Yen, Sun-Yran Chang, Hong-I Chen, Guang-Huan Sun.   

Abstract

BACKGROUND: The incidence of prostate cancer is lower in Taiwan compared to Europe and North America. Only a few urologists have been trained to perform laparoscopic radical prostatectomies (LRP). The initial experience of robotic LRP in Taiwan is reported. PATIENTS AND METHODS: Twenty-four patients with localized prostate carcinomas underwent robotic LRP between November 2004 and December 2006. Data collection included basic demographics, prostate specific antigen (PSA), stages, Gleason scores, operative time, estimated blood loss (EBL), catheterization time, pathology, complications and return of continence.
RESULTS: The mean operative time was 310 minutes, the mean EBL was 234 mL and the average urethral catheterization time was 7.1 days. Three patients had a total of three complications. Continence was 20.8% at one week, 59.1% at six weeks and 75% at three months postoperatively.
CONCLUSION: Our initial experience with robotic LRP indicated that the procedure was safe and effective. Six case experiences were required to establish a standard operating procedure. Eighteen operations were needed to complete the learning curve and achieve stable results.

Entities:  

Mesh:

Year:  2008        PMID: 18649737

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Impact of body mass index on perioperative outcomes during the learning curve for robot-assisted radical prostatectomy.

Authors:  Venu Chalasani; Carlos H Martinez; Darwin Lim; Reem Al Bareeq; Geoffrey R Wignall; Larry Stitt; Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

2.  Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer.

Authors:  Cheng-Pang Hou; Wei-Chang Lee; Yu-Hsiang Lin; Shao-Ming Chen; Chien-Lun Chen; Phei-Lang Chang; Horng-Heng Juang; Ke-Hung Tsui
Journal:  Onco Targets Ther       Date:  2014-12-17       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.